When heart failure reaches its most advanced stage, blood pressure tends to fall and stay low because the heart can no longer pump enough blood to maintain normal circulation. A systolic reading below 90 or 100 mmHg is common, and the resulting symptoms shape much of what patients and families experience in the final phase of the disease. Understanding why blood pressure drops, what it does to the body, and how clinicians try to manage it can help families prepare for the road ahead and make informed decisions about care.
Why Blood Pressure Falls in End-Stage Heart Failure
In a healthy heart, each beat pushes a reliable volume of blood into the arteries, and the vessels maintain enough tension to keep blood pressure in a normal range. In end-stage heart failure with reduced ejection fraction, both sides of that equation break down. The heart’s pumping ability declines, so less blood is ejected per beat. That directly lowers systolic pressure, the top number on a reading. Meanwhile, total blood volume and the degree to which blood vessels relax or constrict determine the bottom number, diastolic pressure. When the heart is severely weakened, the body’s compensatory mechanisms eventually exhaust themselves, and pressure drops further.
Several forces pile on top of each other. The weakened heart muscle is the primary driver, but the very medications that keep heart failure patients alive, including ACE inhibitors, beta-blockers, and vasodilators, also lower blood pressure by design. Diuretics, prescribed to reduce fluid overload, can tip the balance toward too little circulating volume. Comorbidities like diabetes alter how blood vessels respond to signals that would normally tighten them. In practice, low blood pressure in advanced heart failure is rarely caused by a single factor; it is the result of the disease, the treatment, and the body’s fading ability to compensate all happening at once.1PubMed Central. Management of low blood pressure in ambulatory heart failure with reduced ejection fraction patients
What Low Blood Pressure Feels Like Day to Day
Not everyone with a low reading feels terrible. In fact, one of the trickier aspects of managing blood pressure in advanced heart failure is that many patients walk around with readings that would alarm a healthy person but experience few symptoms from the low pressure itself. The most common scenario involves non-severe, asymptomatic low blood pressure in patients who are already on standard heart failure medications.2PubMed. Clinical management and therapeutic optimization of patients with heart failure with reduced ejection fraction and low blood pressure
When low blood pressure does cause symptoms, dizziness and fatigue are usually the first to appear, especially when standing up. This happens because gravity pulls blood toward the legs, and the weakened heart cannot compensate fast enough. A drop of 20 mmHg in systolic pressure or 10 mmHg in diastolic pressure within the first three minutes of standing is a clinical sign that symptoms are pressure-related rather than caused by something else.3PubMed Central. Management of low blood pressure in ambulatory heart failure with reduced ejection fraction patients – Section: Step I: Confirm low blood pressure and assess its link with symptoms Other common complaints include lightheadedness, near-fainting episodes, blurred vision, and a general sense of weakness that makes even short walks feel exhausting. For families, these symptoms can be alarming, but knowing that they are an expected part of the disease’s trajectory can help reduce some of the anxiety around them.
The “Wet and Cold” Problem
Clinicians who specialize in advanced heart failure often sort patients into profiles based on two questions: is the patient congested with fluid (wet), or are they relatively dry? And is blood flow adequate (warm), or is the heart failing to push enough blood forward (cold)? These combinations, sometimes called hemodynamic profiles, help guide treatment decisions. A patient who is “wet and warm” has fluid overload but reasonable blood flow. A patient who is “cold and wet” has both poor blood flow and fluid buildup, the most dangerous combination.4Journal of Cardiac Failure. Clinical Characteristics of Hemodynamic Profiles in Advanced Heart Failure
In the ESCAPE trial, one of the larger studies of advanced heart failure management, patients who were assessed as “cold” at the time of hospital discharge, meaning their hearts were not pushing enough blood forward, had a lower measured cardiac index than “warm” patients. Being discharged with either a “cold” or “wet” profile carried roughly a 50 percent increased risk of death or rehospitalization.5PubMed Central. Value of clinician assessment of hemodynamics in advanced heart failure: the ESCAPE trial This matters for families because the combination of low blood pressure and poor forward blood flow is a signal that the disease has entered a particularly difficult phase, where standard treatments become harder to use and the body’s reserves are running thin.
The Medication Paradox
Here is one of the most frustrating aspects of end-stage heart failure: the drugs proven to extend life all tend to lower blood pressure. ACE inhibitors, angiotensin receptor-neprilysin inhibitors, beta-blockers, and mineralocorticoid receptor antagonists form the backbone of heart failure therapy. They reduce hospitalizations, slow disease progression, and improve survival. But when a patient’s systolic pressure is already hovering around 85 or 90 mmHg, doctors face a real dilemma. Pushing to maintain full doses of these medications risks making the patient dizzy, faint, or worse. Cutting doses or stopping them means removing the drugs that are keeping the patient alive longer.
Current expert consensus strongly advises against prematurely reducing or stopping these life-saving medications just because blood pressure is low, particularly if the patient is not actually experiencing symptoms from the low pressure. The European Society of Cardiology recommends consulting a heart failure specialist rather than reflexively cutting doses.6PubMed Central. Management of low blood pressure in ambulatory heart failure with reduced ejection fraction patients – Section: Expert opinion The first practical step is often to look at diuretics. If a patient shows no signs of fluid congestion, the diuretic dose can sometimes be carefully reduced, which frees up some blood-pressure headroom to maintain the more important medications. This approach has been tested in controlled trials and appears feasible in stable patients.7PubMed Central. Management of low blood pressure in ambulatory heart failure with reduced ejection fraction patients – Section: Proposed five-step algorithm for the management of hypotension in heart failure with reduced ejection fraction patients
For families, this is worth understanding because medication changes in advanced heart failure are rarely straightforward. If a doctor adjusts drug doses, it is not a sign that something has gone wrong with the care plan. It is an ongoing balancing act between keeping blood pressure high enough to function and maintaining the medications that slow the disease.
Inotrope Therapy When Medications Are Not Enough
When standard oral medications can no longer maintain adequate blood flow and blood pressure keeps falling, clinicians sometimes turn to intravenous inotropes, drugs like dobutamine and milrinone that directly strengthen the heart’s contractions and improve forward blood flow. Originally, these drugs were intended as a temporary bridge while patients waited for a heart transplant or a mechanical heart pump. Increasingly, though, patients who are not candidates for those surgical options receive inotropes purely for symptom relief and comfort.
Heart failure experts recommend considering continuous inotrope therapy for patients with stage D heart failure who are clinically decompensating, meaning their condition is deteriorating despite optimal medical management.8Journal of Pain and Symptom Management. End-Stage Heart Failure and Low Blood Pressure: What to Expect These drugs can improve symptoms and functional status, giving patients the ability to feel somewhat better and do more in their remaining time.9PubMed Central. Characteristics and Outcomes of Palliative Continuous Intravenous Inotrope Support Among Medicare Beneficiaries With Heart Failure In some cases, patients receive inotrope infusions at home for extended periods, sometimes spanning years, depending on the healthcare system and available support.10European Journal of Heart Failure. Inotropic Therapy in Patients with Advanced Heart Failure
Inotropes are not without risks. They can cause irregular heart rhythms, and their long-term use has been associated with worse outcomes in some studies. But in the context of end-stage disease, the calculus shifts. The goal is no longer to extend life at any cost but to make the remaining time as comfortable and functional as possible. Families should know that starting inotropes does not necessarily mean death is imminent; it means the care team is prioritizing quality of life.
Transplants and Mechanical Pumps
For a subset of patients with end-stage heart failure and persistently low blood pressure, more aggressive interventions remain on the table. Heart transplantation is the most definitive option, replacing the failing organ entirely. Left ventricular assist devices, small mechanical pumps surgically implanted to help the heart push blood forward, serve as either a bridge to transplant or a long-term therapy in their own right. Timely referral to a center that evaluates patients for these options plays a key role in favorable outcomes.11PubMed. Evaluation for Heart Transplantation and LVAD Implantation: JACC Council Perspectives
Not everyone qualifies. Age, other organ damage, frailty, and personal preference all factor in. Patients classified as “cold and dry,” meaning they have low blood flow but are not heavily fluid-overloaded, represent a particularly challenging group. Research from a large registry examined LVAD outcomes in these patients using pre-implant measurements to categorize them by their hemodynamic profile.12PubMed. Left Ventricular Assist Device Therapy in Cold and Dry Patients Identifying where a patient falls in these categories helps determine whether surgical intervention is likely to help or whether the focus should shift toward comfort-oriented care.
What Low Blood Pressure Signals About Prognosis
Blood pressure in heart failure follows a pattern that surprises many people. In the general population, high blood pressure is the danger. In heart failure, the relationship reverses: lower blood pressure predicts worse outcomes. This so-called “reverse epidemiology” of blood pressure in heart failure is one of the more consistent findings in the field.
A study of heart failure patients found that those with systolic blood pressure below 100 mmHg had an adjusted mortality rate of 50 percent over the study period, compared to 32 percent for patients with systolic readings between 130 and 139 mmHg. The relationship between lower blood pressure and higher mortality was significant and nonlinear, meaning the risk accelerated as pressure dropped.13PubMed. The association between blood pressure and mortality in patients with heart failure More recent work confirms the pattern: in patients hospitalized with acute heart failure, an initial systolic reading below 120 mmHg was associated with roughly an 80 percent higher risk of adverse outcomes after adjusting for other factors.14PubMed Central. Effect of low blood pressure on prognosis of acute heart failure Another study found that patients discharged from the hospital with systolic pressure below 130 mmHg had higher mortality and lost more years of life compared to those who maintained or improved to higher readings.15European Journal of Internal Medicine. Systolic blood pressure, a predictor of mortality and life expectancy following heart failure hospitalization, 2010–2023
For families watching a loved one’s blood pressure readings trend downward, these numbers can be difficult to hear. It is worth remembering that these are population-level statistics. An individual patient’s trajectory depends on many factors beyond blood pressure alone, including how well they respond to treatment adjustments, their overall frailty, and the presence of other illnesses. But persistently low blood pressure that resists all efforts to improve it is one of the clearer signs that the heart’s reserves are nearly gone.
Effects on Thinking and Memory
One of the less discussed consequences of low blood pressure in advanced heart failure is its effect on the brain. When the heart cannot push enough blood forward, the brain receives less oxygen and nutrients than it needs. Over time, this reduced blood flow can lead to noticeable changes in thinking, memory, and the ability to make decisions.
Research has found a selective association between low systolic blood pressure and cognitive impairment in older heart failure patients. The investigators recommended that routine heart failure management should include systematic assessment of cognitive performance, because early treatment of low-output states can sometimes reverse the cognitive decline.16PubMed. Hypotension and cognitive impairment: Selective association in patients with heart failure The cognitive changes tend to affect attention, memory, executive function, and processing speed. These deficits can interfere with a patient’s ability to manage their own medications, recognize worsening symptoms, and participate in decisions about their care. The severity of cognitive impairment can fluctuate: it sometimes improves when heart failure treatment is optimized, but it can also progress toward dementia if the underlying circulation problems persist.17PubMed Central. Cognitive impairment in heart failure
This has real practical consequences. A patient who seemed sharp and engaged a few months ago may now struggle to remember whether they took their medications or may not recognize that their breathing has worsened. Families should not assume these changes are simply “getting old” or depression, though both can coexist. Bringing up cognitive concerns with the care team is important, because adjustments to treatment can sometimes improve mental clarity, at least temporarily.
Decisions About Implanted Devices
Many patients with advanced heart failure have implantable cardioverter-defibrillators, devices that deliver an electric shock to restore a normal heart rhythm during a life-threatening arrhythmia. Some also have pacemakers or mechanical circulatory support systems. As the disease reaches its final stage, a question arises that families often find difficult: should these devices be turned off?
Current guidelines from professional societies affirm that deactivating life-sustaining devices is both ethically and legally permissible when requested by patients or their surrogates who have decision-making capacity. In the case of defibrillators specifically, deactivation prevents painful and unnecessary shocks at the end of life, shocks that can prolong the process of dying without improving quality of life. Guidelines also recommend that discussions about potential future deactivation be included in the consent process before the device is even implanted, though in practice these conversations remain infrequent.18PubMed. Deactivation of Cardiac Devices at the End of Life: Clinical and Ethical Challenges
Families are sometimes caught off guard by this decision because a device that once provided reassurance, knowing it would “catch” a dangerous rhythm, now represents a source of suffering. Patients in the final days of life who have active defibrillators can receive repeated shocks that cause pain and distress without changing the ultimate outcome. Having this conversation early, ideally while the patient can still participate, removes a heavy burden from family members who might otherwise have to make the call during a crisis.
Planning for Comfort and End-of-Life Care
When quality of life outweighs the goal of extending life, the transition to end-of-life care should be considered. This involves advance care planning that covers resuscitation preferences such as do-not-resuscitate orders, decisions about device deactivation, where the patient wants to spend their final days, and bereavement support for the family.19PubMed Central. End-of-Life Care for End-stage Heart Failure Patients These plans should be reviewed regularly, because the patient’s condition and preferences can change.
Heart failure presents a unique challenge for end-of-life planning compared to diseases like cancer. The trajectory is unpredictable. Patients can have multiple acute episodes, recover partially, and then decline again over months or years. This pattern of repeated crises and partial recoveries makes it genuinely hard to identify the “right” moment to shift from aggressive treatment to comfort-focused care. Many families and even clinicians delay the conversation, hoping the next hospitalization will be the one the patient bounces back from.
International guidelines on end-of-life care for heart failure patients consistently emphasize that discussions about overall goals of care and individual preferences should happen early and revisited often, not just at the very end. Caregivers of end-stage heart failure patients need supportive care themselves to prevent burnout and maintain their ability to provide care.20PubMed. End-Of-Life Care for Patients With End-Stage Heart Failure, Comparisons of International Guidelines Hospice and palliative care teams experienced with heart failure can help manage symptoms like breathlessness, pain, and anxiety while also supporting family members through the process. If a patient is receiving home inotrope therapy, palliative teams can often coordinate with the cardiology team to continue that treatment while focusing the overall plan on comfort.
What Caregivers Can Watch For
Families living with someone in end-stage heart failure often become informal monitors, noticing changes before the next clinic visit. A few patterns related to low blood pressure are worth recognizing. Increased drowsiness or confusion during the day, especially after standing or walking, can signal that the brain is not getting enough blood flow. A loved one who becomes unsteady on their feet, who stops wanting to get up, or who seems less “present” during conversations may be experiencing the cognitive effects of poor circulation described above.
Urine output tends to decrease as blood pressure falls, because the kidneys need a minimum amount of pressure to filter blood effectively. Swelling in the legs and abdomen, or sudden weight gain over a day or two, usually points to fluid retention and suggests the “wet” side of the hemodynamic profile. A sudden worsening of breathlessness, even at rest, alongside falling blood pressure can indicate that the heart is losing its ability to compensate and may warrant a call to the care team. Keeping a simple daily log of weight, blood pressure if measurable at home, and a brief note on how the patient felt can give clinicians much more useful information than a snapshot taken during a brief office visit.
Perhaps the hardest thing for caregivers is accepting that some of these changes are not reversible. There is a natural instinct to push for more tests, more medication adjustments, more interventions. Sometimes those help. But when blood pressure remains stubbornly low despite every reasonable medical effort, it reflects the heart’s inability to do its job. Recognizing that reality, without feeling like you have given up, is one of the most difficult emotional tasks caregiving demands.